Advertisement

Topics

Latest Clinical Approvals NewsRSS

21:07 EST 23rd November 2017 | BioPortfolio

Itamar Medical Ltd ITMR Financial and Strategic SWOT Analysis Review [Report Updated: 13112017] Prices from USD $300

SummaryItamar Medical Ltd Itamar Medical is a medical device company that offers biomedical technology products. The company develops, markets and distributes diagnostic medical devices. Its products include EndoPAT, a medical device for the diagnosis of endothelial dysfunction; and WatchPAT, a diagnostic device which provides accurate screening, detection, and diagnosis of sleep apnea and sleep d...

Nawaloka Hospitals PLC NHL.N0000 Financial and Strategic SWOT Analysis Review [Report Updated: 13112017] Prices from USD $300

SummaryNawaloka Hospitals Plc Nawaloka is a healthcare service provider that offers clinical and diagnostic services. The hospital provides diagnostic services such as angiography, ultrasound scanning, CT scanning, dexa scanning, exercise ECG, diabetes screening, dopler scanning, echo cardiography, endoscopy, holter monitoring, MRI scanning and Xray facilities, among others. Its clinical services ...

Miraca Holdings Inc 4544 Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 14112017] Prices from USD $250

SummaryMiraca Holdings Inc Miraca Holdings is a medical laboratory that operates in three business segments such as clinical diagnostic segment, entrusted clinical examination segment and healthcare segment. The company's clinical diagnostic segment manufactures and sells clinical diagnostics. Its entrusted clinical examination segment includes special clinical examination, the general clinical ex...

Type 2 Diabetes Mellitus [2017] [Report Updated: 01092017] Prices from USD $8145

Will novel therapies transform the treatment of type 2 diabetes?The treatment of type 2 diabetes mellitus has evolved in recent years with introduction of new classes of molecules. While the wide array of treatment options including SGLT2 inhibitors, GLP1 agonists and newer insulin therapies provide individualised therapy, unmet needs persist in the market for effective modalities that can provi...

Edinburgh Bioquarter Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 14112017] Prices from USD $250

SummaryEdinburgh Bioquarter BioQuarter is an academic medical center that offers translational medicine research services. The center develops new treatments for human and animal diseases by creating new drugs, diagnostic tools and medical devices. It conducts research in the field of regenerative medicine, inflammation and oncology. BioQuarter offers advance drug development by transforming basic...

KMT Hepatech Announces Strategic Investment From PhoenixBio

KMT Hepatech, Inc. (“KMT”) announced today that it has reached an agreement to join efforts with PhoenixBio Co., Ltd. (PhoenixBio). Together they will advance the use of the cDNA-uPA/SCID mouse model with highly humanized liver to support researchers across a wide range of drug development fields. KMT will become a subsidiary of PhoenixBio group effect...

Capricor's 12-Month Results Brings HOPE to a Registration Trial

On Wednesday, November 15, 2017, Capricor Therapeutics (CAPR) announcedthe 12-month results of its HOPE-Duchenne (AKA HOPE1) study, and held a conference callwith presentation slides. Capricor intends to use its CAP-1002treatment to increase overall muscle functioning in Duchenne muscular dystrophy (DMD) patients.  The announcement coincided with a scientific presentation delivered at the Ann...

Curetis (CURE-NL): Focus on US launch

goetzpartners securities Limited 23-Nov-2017 / 16:52 GMT/BST This equity research note was formally published on 17th November 2017 at 5.00am. Curetis (CURE-NL): Focus on US launch Recommendation: OUTPERFORM Target price: EUR10.00 Current price (as at 17th Nov 2017): EUR3.75 Sluggish EU sales growth and slippage in the installed base target into Q1/2018 were sure to disappoint. While ...

Global Bioactive Glass Market 20172021 [Report Updated: 16112017] Prices from USD $3500

About Bioactive GlassBioactive glass is a surfacereactive glassceramic biomaterial. The biocompatibility and bioactivity of these glasses have led to it being used as an implant in the human body, especially to repair and replace diseased or damaged bones. Bioactive glass is an important category of bioactive materials with a wide range of applications in tissue repair materials which are majorly ...

Canada Clinical Chemistry Market Outlook to 2024 [Report Updated: 06112017] Prices from USD $4995

Canada Clinical Chemistry Market Outlook to 2024SummaryGlobalData's new report, Canada Clinical Chemistry Market Outlook to 2024, provides key market data on the Canada Clinical Chemistry market. The report provides value, in millions of US dollars, volume in units and average prices USD within market segments Blood Test Strips Rapid Tests POC, Clinical Chemistry Analyzers, Clinical Chemistry R...

Brazil Clinical Chemistry Market Outlook to 2024 [Report Updated: 06112017] Prices from USD $4995

Brazil Clinical Chemistry Market Outlook to 2024SummaryGlobalData's new report, Brazil Clinical Chemistry Market Outlook to 2024, provides key market data on the Brazil Clinical Chemistry market. The report provides value, in millions of US dollars, volume in units and average prices USD within market segments Blood Test Strips Rapid Tests POC, Clinical Chemistry Analyzers, Clinical Chemistry R...

Mexico Clinical Chemistry Market Outlook to 2024 [Report Updated: 06112017] Prices from USD $4995

Mexico Clinical Chemistry Market Outlook to 2024SummaryGlobalData's new report, Mexico Clinical Chemistry Market Outlook to 2024, provides key market data on the Mexico Clinical Chemistry market. The report provides value, in millions of US dollars, volume in units and average prices USD within market segments Blood Test Strips Rapid Tests POC, Clinical Chemistry Analyzers, Clinical Chemistry R...

Australia Clinical Chemistry Market Outlook to 2024 [Report Updated: 06112017] Prices from USD $4995

Australia Clinical Chemistry Market Outlook to 2024SummaryGlobalData's new report, Australia Clinical Chemistry Market Outlook to 2024, provides key market data on the Australia Clinical Chemistry market. The report provides value, in millions of US dollars, volume in units and average prices USD within market segments Blood Test Strips Rapid Tests POC, Clinical Chemistry Analyzers, Clinical Ch...

India Clinical Chemistry Market Outlook to 2024 [Report Updated: 06112017] Prices from USD $4995

India Clinical Chemistry Market Outlook to 2024SummaryGlobalData's new report, India Clinical Chemistry Market Outlook to 2024, provides key market data on the India Clinical Chemistry market. The report provides value, in millions of US dollars, volume in units and average prices USD within market segments Blood Test Strips Rapid Tests POC, Clinical Chemistry Analyzers, Clinical Chemistry Rapi...

PAION ANNOUNCES CLINICAL DEVELOPMENT PROGRESS WITH REMIMAZOLAM BY ITS PARTNER HANA PHARM IN SOUTH KOREA

DGAP-News: PAION AG / Key word(s): Research Update 23.11.2017 / 14:00 The issuer is solely responsible for the content of this announcement. PAION ANNOUNCES CLINICAL DEVELOPMENT PROGRESS WITH REMIMAZOLAM BY ITS PARTNER HANA PHARM IN SOUTH KOREA - Hana Pharm plans to start a Phase III trial in general anesthesia in 2018 - IND approved on 31 October 2017 - Hana Pharm plans to submit a ...

Positive Interim Data Reported From Intravenous Immunoglobulin Phase 3 Trial

NewsInterim clinical data shows non inferiority to commercially-approved products for primary immunodeficiencies. The information meets Health Canada's requirements for a New Drug Submission (NDS) filing.

Making Institut Curie a Reference for Technology Transfer in Oncology

Institut Curie has adopted an ambitious strategy for technology transfer and partnerships with innovative companies. This new dynamic, initiated within the framework of the 2015-2020 MC21 strategic plan (Marie Curie in the 21st century), aims at positioning the Institut Curie as a reference for technology transfer in oncology. The strategy ...

Acerus Announces Licensing Of NATESTO® In Brazil

Acerus Pharmaceuticals Corporation (TSX:ASP) today announced the signing of an agreement granting Apsen Farmacêutica (Apsen) the exclusive right to market NATESTO® in Brazil. Apsen is a leading Brazilian based pharmaceutical company with over 40 products and 1,100 employees in that country. “We are pleased to be partnering with Apsen, a lead...

Resonance Health Ltd RHT Medical Equipment Deals and Alliances Profile [Report Updated: 08112017] Prices from USD $250

SummaryResonance Health Ltd Resonance Health is a healthcare solution provider that offers noninvasive medical imaging software and services. The company's products and services include FerriScan analysis software for the measurement of liver iron concentration LIC; FerriScan with Cardiac T2* dual analysis service to enable physicians to manage patients at risk of ironinduced organ damage. It also...

CPi Global CRO joins SCRS as Global Impact Partner

Princeton, NJ-based CPi Global CRO has joined the Society for Clinical Research Sites (SCRS) as a Global Impact Partner.

MorphoSys Announces That Its Licensee Janssen Has Received Approval for Tremfya(R) (Guselkumab) in Europe for the Treatment of Moderate-to-Severe Plaque Psoriasis (news with additional features)

DGAP-News: MorphoSys AG / Key word(s): Regulatory Approval 23.11.2017 / 10:19 The issuer is solely responsible for the content of this announcement. Planegg/Munich, Germany, November 23, 2017 MorphoSys Announces That Its Licensee Janssen Has Received Approval for Tremfya(R) (Guselkumab) in Europe for the Treatment of Moderate-to-Severe Plaque Psoriasis MorphoSys entitled to royalties...

Infant Bacterial Therapeutics AB (publ) Interim Management Statement, January 1 - September 29, 2017

Message from the CEO IBT announced results from the safety and tolerability study of IBP-9414 on September 11th. The data demonstrate a similar safety and tolerability profile in the active and placebo groups. The study included 120 preterm infants, dosed during two weeks and evaluated at time points up to 6 months after administration of the study drug at 15 neonatal centers in ...

Saniona AB: Saniona AB's Nomination Committee for the 2018 Annual General Meeting

PRESS RELEASE November 23, 2017 The Annual General Meeting on May 23, 2017, resolved that a Nomination Committee shall be appointed before coming election and remuneration. The Nomination Committee shall comprise three members, which should be representative for the two largest shareholders as of last September, together with the Chairman of the Board of Directors. On September 30,...

#jobs #lifescience Sr. Clinical Documentation Associate

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Sr. Clinical Documentation Associate .NY-Tarrytown, Job Summary and Essential Functions: Known for its scientific and operational excellence, Company is a leading science-based biopharmaceutical company that discovers, invents, develops, … Continue reading → Cet ar...

CMIC Holdings Co Ltd 2309 Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 14112017] Prices from USD $250

SummaryCMIC Holdings Co Ltd CMIC is a contract research organization that supports drug development services. The organization offers medical research related services to pharmaceuticals and medical organizations. Its CRO business services include monitoring, data management, STAT analysis, registration, eclinical trials, quality management, quality assurance, pharmacovigilance and medical writing...

Quick Search
Advertisement
 

review and buy Clinical Approvals market research data and corporate reports here